FullHope Biomedical Co.,Ltd. (TPEX:7773)
Taiwan · Delayed Price · Currency is TWD 29.50
+0.20 (0.68%)
At close: Oct 8, 2026
FullHope Biomedical Market Cap
FullHope Biomedical has a market cap or net worth of 1.18 billion as of October 9, 2026. It is the 32,659th most valuable company in the world and the 1,969th biggest in Taiwan. Its market cap has decreased by 21.23% in one year.
Market Cap
1.18B
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#1,969 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since September 26, 2024, FullHope Biomedical's market cap has decreased from 2.19B to 1.18B, a decrease of -46.27%. That is a compound annual growth rate of -26.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 1.18B | -3.75% |
| Dec 31, 2025 | 1.22B | -21.71% |
| Dec 31, 2024 | 1.56B | -28.69% |
| Sep 26, 2024 | 2.19B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 23.17B |
| Elixiron Immunotherapeutics (Cayman) Limited | 19.60B |
| Obigen Pharma | 9.19B |
| Intelligene | 7.98B |
| Uwell Biopharma | 5.66B |
| Tripartite Therapeutics | 5.34B |
| Pet Pharm Biotech | 3.04B |
| BIONET Therapeutics | 2.58B |